The global breast cancer brachytherapy market is estimated to be valued at USD 961.1 Mn in 2025 and is expected to reach USD 1,544.3 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.0% from 2025 to 2032.
To learn more about this report, Request sample copy
The non-invasive nature and localized radiation dose delivered make brachytherapy an attractive treatment option for breast cancer. Technological advancements in brachytherapy such as high dose rate and intensity modulated brachytherapy are improving the efficacy and outcome of the treatment.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients